Clinical Trials Browser

OTHER × Lymphoma, T-Cell × Tetrahydrouridine × Clear all

NCT02846935 2019-01-07

p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies

Phase EARLY_PHASE1 Completed

Lymphoma, T-Cell